Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
521.2 USD | +0.71% | +2.80% | -1.00% |
May. 15 | UnitedHealth Group Incorporated Announces Management Changes, Effective June 4, 2024 | CI |
May. 10 | Stephens Adjusts Price Target on UnitedHealth to $565 From $545 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Analyst opinion has improved significantly over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company benefits from high valuations in earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.00% | 476B | B- | ||
+15.34% | 126B | A- | ||
+13.31% | 97.52B | B- | ||
-22.40% | 41.83B | A- | ||
+3.95% | 41.67B | B- | ||
-4.51% | 20.27B | B- | ||
-25.90% | 2.55B | C+ | ||
-18.82% | 1.35B | B- | ||
-2.14% | 469M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UNH Stock
- Ratings UnitedHealth Group Inc.